• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布洛芬缓释微球的立体特异性制剂及表征

Stereospecific formulation and characterization of sustained release ibuprofen microspheres.

作者信息

Janjikhel R K, Adeyeye C M

机构信息

Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA 15282, USA.

出版信息

J Microencapsul. 1997 Jul-Aug;14(4):409-26. doi: 10.3109/02652049709033826.

DOI:10.3109/02652049709033826
PMID:9229341
Abstract

Ibuprofen microspheres were prepared from the racemate, (+)-S and (-)-R enantiomers using waxes such as ceresine and glyceryl stearate and stereospecifically characterized. The method of preparation of the microspheres was a hydrophobic congealable disperse phase encapsulation process and variables such as particle size, wax type, enantiomeric form were evaluated. Dissolution studies were carried out by a modified USP type II method and the samples were analysed by a stereospecific HPLC assay using S-(-)-1(1) naphthylethylamine as the derivatizing agent and fenoprofen as the internal standard. The mean particle sizes of (+)-S and (-)-R enantiomers determined by microscopy/image analysis were 64 and 99 microns respectively while that of the racemate was 48 microns. Differential Scanning Calorimetry (DSC) of ibuprofen and the enantiomers showed endothermic peaks at 72 and 55 degrees C respectively. Thermograms of the physical mixture and microspheres did not show the characteristic ibuprofen peak, indicating a change in crystallinity of the drug. Powder X-ray diffraction patterns of the enantiomers and racemic ibuprofen were found to be dissimilar indicating different crystal properties. The X-ray patterns for the microspheres did not show the characteristic peaks for the drug indicating that ibuprofen may be in solid solution with the waxes. Scanning electron micrographs of the microspheres showed a generally smooth and spongy appearance for the microspheres made of compritol and glyceryl stearate. Microspheres made from the paraffin waxes had rough and hard surface characteristics consistent with the higher melting point of the waxes. Ceresine microspheres made with the enantiomers had a rougher and more porous surface compared to the microspheres made with racemic ibuprofen. Stereospecific release of the recemate from the formulations was found to be sustained (T25 of 4 h), while release from the enantiomers was less sustained (T50 of 2 h). From the S:R ratios and statistical analysis of the data, the release of the enantiomers of ibuprofen from the formulations containing the racemate was found to be non-stereoselective.

摘要

使用诸如微晶蜡和硬脂酸甘油酯等蜡,由外消旋体、(+)-S和(-)-R对映体制备布洛芬微球,并对其进行立体特异性表征。微球的制备方法是疏水可凝结分散相包封法,并评估了诸如粒径、蜡类型、对映体形式等变量。采用改良的美国药典II型方法进行溶出度研究,并使用S-(-)-1(1)萘乙胺作为衍生剂、非诺洛芬作为内标,通过立体特异性高效液相色谱法对样品进行分析。通过显微镜/图像分析测定,(+)-S和(-)-R对映体的平均粒径分别为64微米和99微米,而外消旋体的平均粒径为48微米。布洛芬及其对映体的差示扫描量热法(DSC)分别在72℃和55℃显示吸热峰。物理混合物和微球的热重曲线未显示出布洛芬的特征峰,表明药物的结晶度发生了变化。发现对映体和外消旋布洛芬的粉末X射线衍射图谱不同,表明晶体性质不同。微球的X射线图谱未显示出药物的特征峰,表明布洛芬可能与蜡形成固溶体。微球的扫描电子显微镜照片显示,由硬脂醇和硬脂酸甘油酯制成的微球通常外观光滑且呈海绵状。由石蜡制成的微球具有粗糙且坚硬的表面特征,这与蜡的较高熔点一致。与由外消旋布洛芬制成的微球相比,由对映体制成的微晶蜡微球表面更粗糙且孔隙更多。发现制剂中外消旋体的立体特异性释放是持续的(T25为4小时),而对映体的释放持续性较差(T50为2小时)。根据S:R比值和数据统计分析,发现含有外消旋体的制剂中布洛芬对映体的释放是非立体选择性的。

相似文献

1
Stereospecific formulation and characterization of sustained release ibuprofen microspheres.布洛芬缓释微球的立体特异性制剂及表征
J Microencapsul. 1997 Jul-Aug;14(4):409-26. doi: 10.3109/02652049709033826.
2
Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres.布洛芬及布洛芬蜡质微球缓释制剂混悬液的化学、溶出稳定性及微观评价
J Microencapsul. 1997 May-Jun;14(3):357-77. doi: 10.3109/02652049709051139.
3
Development and evaluation of sustained-release ibuprofen-wax microspheres. I. Effect of formulation variables on physical characteristics.缓释布洛芬蜡质微球的研制与评价。I. 制剂变量对物理特性的影响。
Pharm Res. 1991 Nov;8(11):1377-83. doi: 10.1023/a:1015845022112.
4
Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.使用泊洛沙姆407固体分散体提高布洛芬的溶出度。
Arch Pharm Res. 2008 Nov;31(11):1497-507. doi: 10.1007/s12272-001-2136-8. Epub 2008 Nov 21.
5
Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables.采用准乳液溶剂扩散法制备及评价含丙烯酸聚合物(尤特奇)的布洛芬缓释微球:变量的影响
Acta Pol Pharm. 2006 Nov-Dec;63(6):521-34.
6
Determination of ibuprofen solubility in wax: a comparison of microscopic, thermal and release rate techniques.布洛芬在蜡中溶解度的测定:微观、热学和释放速率技术的比较
Eur J Pharm Biopharm. 2007 Aug;67(1):106-11. doi: 10.1016/j.ejpb.2007.01.009. Epub 2007 Jan 27.
7
In-vitro evaluation of sustained release ibuprofen microspheres.布洛芬缓释微球的体外评价
P R Health Sci J. 1996 Jun;15(2):97-100.
8
Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies.缓释布洛芬蜡质微球的研制与评价。II. 体外溶出度研究。
Pharm Res. 1994 Apr;11(4):575-9. doi: 10.1023/a:1018931002991.
9
Comminution of ibuprofen to produce nano-particles for rapid dissolution.将布洛芬粉碎制成纳米颗粒以实现快速溶解。
Int J Pharm. 2011 Aug 30;415(1-2):307-14. doi: 10.1016/j.ijpharm.2011.06.002. Epub 2011 Jun 12.
10
Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.新型口服制剂(布洛芬精氨酸)给药后,健康男性志愿者体内布洛芬对映体的初步药代动力学研究。
Chirality. 1997;9(3):297-302. doi: 10.1002/(SICI)1520-636X(1997)9:3<297::AID-CHIR16>3.0.CO;2-I.

引用本文的文献

1
Evaluation of gum mastic as a microencapsulating and matrix forming material for sustained drug release.乳香作为用于药物缓释的微囊化和基质形成材料的评估。
Asian J Pharm Sci. 2017 Sep;12(5):424-432. doi: 10.1016/j.ajps.2017.05.002. Epub 2017 May 10.
2
PEGylated rosin derivatives: novel microencapsulating materials for sustained drug delivery.聚乙二醇化松香衍生物:用于药物缓释的新型微囊包封材料。
AAPS PharmSciTech. 2007 Jun 22;8(2):Article 47. doi: 10.1208/pt0802047.